Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials.
Takayuki HamanoYusuke YamaguchiKashia GotoShaka MartinAlina JiletcoviciFrank DellannaTadao AkizawaJonathan BarrattPublished in: Advances in therapy (2024)
NCT02278341, NCT02273726, NCT02052310, NCT02174731.